All the groups showed a trend that all-cause mortality was increased with the decreased renal function (eGFRcys: group 1 to group 3, 2.9–22.6%; eGFRcre: group 1 to group 3 5.7–20.0%; eGFRcre-cys: group 1 to group 3, 4.3–23.0%; and eGFR-MDRD: group 1 to group 3, 7.0–17.2%).
← all excerpts
Cystatin C-Based Renal Function in Predicting the Long-Term Outcomes of Chronic Total Occlusion After Percutaneous Coronary Intervention.
1
—
—